Losses & Lawsuits

- Risk Staff
- 01 Dec 2005

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Durus Capital Management

The US Securities and Exchange Commission filed on October 12 fraud charges against hedge fund Durus Capital Management, and its principals, Scott Sacane and J Douglas Schmidt. The SEC complaint charges Sacane and Schmidt with instigating fraudulent schemes during 2002 and 2003 involving the common stock of two biotechnology companies: Esperion Therapeutics and Aksys. Schmidt has since pleaded guilty to filing false statements.

Once the alleged frauds were disclosed in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact info@risk.net to find out more.

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net